SynbiCITE sponsors new award for synthetic biology
- Posted on 2 October, 2015
SynbiCITE is proud to be the first sponsor of the new OBN Award for Best Emerging UK SynBio Company.
The winner is Oxitec and the award was announced last night, Thursday 1st October at the Ashmolean Museum in Oxford. Oxitec won the award for developing pioneering solutions to control insects that spread human disease and damage crops.
Dr Steve Chambers, CEO of SynbiCITE said “All the SynBio companies at the OBN awards, nominees and winners, represent the very best of synthetic biology in the UK. We are privileged to be able help them work towards commercialisation of ground breaking and disruptive technology.
SynbiCITE partner Touchlight Genetics won the award for Best Emerging UK Biotech Company.
You can find out more about the event and details of all last night's winners on OBN's website.
Share this article:
People also read
Measurement for Recovery
Measurement for RecoveryNew programme to help boost competitiveness and resilience of UK industry, led by the National Physical Laboratory (NPL)NPL is...
SynbiTECH2020 is going virtual!
SynbiTECH 2020 is now entirely virtual to ensure everyone can join us to discuss the latest transformations in synthetic biology and its contribution to the global bioeconomy.
Evonetix raises $30 million USD (£23 million GBP)
Series B investment led by west-coast investor Foresite Capital, with all existing investors participating in the roundFunds will be used to accelerat...